Therapeutic Agents Rounding Up the Immunopathology of COVID-19
HP Li, X He, L Zhang, CX Li, SQ Li… - Therapeutics and Clinical …, 2021 - Taylor & Francis
COVID-19 pandemic has caused more than 3 million deaths globally during the past year.
The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the …
The direct attack from SARS-CoV-2 and hyperactivated immune response contribute to the …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
[HTML][HTML] Adjunct immunotherapies for the management of severely ill COVID-19 patients
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
M Razmi, F Hashemi, E Gheytanchi… - International …, 2020 - Elsevier
The global panic of the novel coronavirus disease 2019 (COVID-19) triggered by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent requirement …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent requirement …
Therapeutic role of immunomodulators during the COVID-19 pandemic–a narrative review
H Al-Hajeri, F Baroun, F Abutiban… - Postgraduate …, 2022 - Taylor & Francis
The emergency state caused by COVID-19 saw the use of immunomodulators despite the
absence of robust research. To date, the results of relatively few randomized controlled trials …
absence of robust research. To date, the results of relatively few randomized controlled trials …
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
The novel coronavirus pandemic has emerged as one of the significant medical-health
challenges of the current century. The World Health Organization has named this new virus …
challenges of the current century. The World Health Organization has named this new virus …
Advances in immunotherapy for COVID-19: A comprehensive review
M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
Cytokine Storm and Immunomodulation in COVID-19: A Review
AM Arsh, S Mishra, V Tripathi, A Mishra - Coronaviruses, 2022 - ingentaconnect.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has taken
over the world, and more than 38 lakh deaths had been reported till now due to this …
over the world, and more than 38 lakh deaths had been reported till now due to this …
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …